In BriefBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1748 (Published 26 March 2010) Cite this as: BMJ 2010;340:c1748
World’s poorest children to receive pneumococcal vaccine: Millions of infants and young children in the world’s poorest countries will receive vaccines that help protect against pneumococcal disease, including pneumonia—the world’s biggest childhood killer, the GAVI Alliance has announced. GlaxoSmithKline and Pfizer are the first two companies to make long term commitments to supply new vaccines against pneumococcal disease. Supply may start in 2010, and at a fraction of the price charged in industrialised …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial